(Q39517953)

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

12 September 2017

2 references

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

title

Enhanced cellular uptake and in vivo pharmacokinetics of rapamycin-loaded cubic phase nanoparticles for cancer therapy (English)

1 reference

12 September 2017

1 reference

Priyambada Parhi

1

1 reference

12 September 2017

Chandana Mohanty

series ordinal

2

1 reference

12 September 2017

Sanjeeb Kumar Sahoo

series ordinal

3

1 reference

12 September 2017

publication date

15 June 2011

1 reference

12 September 2017

1 reference

12 September 2017

volume

7

1 reference

12 September 2017

issue

10

1 reference

12 September 2017

page(s)

3656-3669

1 reference

Epithelial cell adhesion molecule targeted nutlin-3a loaded immunonanoparticles for cancer therapy

12 September 2017

cites work

2 references

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1016/J.ACTBIO.2010.08.010

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

Enhanced antiproliferative activity of carboplatin-loaded chitosan-alginate nanoparticles in a retinoblastoma cell line

2 references

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1016/J.ACTBIO.2010.02.010

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

Caspase independent/dependent regulation of K(+), cell shrinkage, and mitochondrial membrane potential during lymphocyte apoptosis

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

Targeted epidermal growth factor receptor nanoparticle bioconjugates for breast cancer therapy

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

Solubilization of rapamycin

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

Rapamycin promotes beta-amyloid production via ADAM-10 inhibition

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

Optimization of physicochemical parameters influencing the fabrication of protein-loaded chitosan nanoparticles

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

The emerging nanomedicine landscape

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

Incidence, mechanism and prognostic value of activated AKT in pancreas cancer

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

Pluronic block copolymers: novel functional molecules for gene therapy

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

mTOR and cancer therapy

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

Activation of mammalian target of rapamycin signaling pathway contributes to tumor cell survival in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

Patient preference and pharmacokinetics of oral modulated UFT versus intravenous fluorouracil and leucovorin: a randomised crossover trial in advanced colorectal cancer

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

When translation meets transformation: the mTOR story

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

Cytoplasmic and nuclear distribution of the protein complexes mTORC1 and mTORC2: rapamycin triggers dephosphorylation and delocalization of the mTORC2 components rictor and sin1.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

Nanotech approaches to drug delivery and imaging

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

Mitochondria and apoptosis

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

Nanoparticles of biodegradable polymers for clinical administration of paclitaxel

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

The in vitro sub-cellular localization and in vivo efficacy of novel chitosan/GMO nanostructures containing paclitaxel

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

Multifunctional Gold Nanoparticle−Peptide Complexes for Nuclear Targeting

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

Sustained antibacterial activity of doxycycline-loaded poly(D,L-lactide-co-glycolide) and poly(epsilon-caprolactone) nanoparticles

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

Rapamycin, a potent immunosuppressive drug, causes programmed cell death in B lymphoma cells

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

Self-assembled nanoparticles of poly(lactide)--Vitamin E TPGS copolymers for oral chemotherapy.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

A novel nanoparticle formulation for sustained paclitaxel delivery

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

Distribution of sirolimus in rat tissue

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

Ligand-based targeted therapy for cancer tissue

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

Phase ii comparator study of oral versus intravenous topotecan in patients with chemosensitive small-cell lung cancer

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

Intracellular trafficking of nuclear localization signal conjugated nanoparticles for cancer therapy

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

Epigallocatechin-3-gallate induces mitochondrial membrane depolarization and caspase-dependent apoptosis in pancreatic cancer cells

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

Influence of vitamin E TPGS poly(ethylene glycol) chain length on apical efflux transporters in Caco-2 cell monolayers

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

A novel in situ gel for sustained drug delivery and targeting

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

Protein nanoparticles as drug carriers in clinical medicine

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

The TOR pathway: a target for cancer therapy

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

In vivo characterization of a polymeric nanoparticle platform with potential oral drug delivery capabilities

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

The in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulation

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

Challenges and solutions for the delivery of biotech drugs--a review of drug nanocrystal technology and lipid nanoparticles

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

The present and future of nanotechnology in human health care

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

Dual drug loaded superparamagnetic iron oxide nanoparticles for targeted cancer therapy

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

Recent developments in targeting the mammalian target of rapamycin (mTOR) kinase pathway

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

The rapamycin-sensitive signal transduction pathway as a target for cancer therapy

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

Relationships between the hydrophilic-lipophilic balance values of pharmaceutical excipients and their multidrug resistance modulating effect in Caco-2 cells and rat intestines

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

Efficacy of transferrin-conjugated paclitaxel-loaded nanoparticles in a murine model of prostate cancer

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

Composite polymeric magnetic nanoparticles for co-delivery of hydrophobic and hydrophilic anticancer drugs and MRI imaging for cancer therapy.

2 references

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1021/AM101196V

Nanoparticle agglutination: acceleration of aggregation rates and broadening of the analyte concentration range using mixtures of various-sized nanoparticles

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

Curcumin-encapsulated MePEG/PCL diblock copolymeric micelles: a novel controlled delivery vehicle for cancer therapy

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

Sustained activation of the JNK cascade and rapamycin-induced apoptosis are suppressed by p53/p21(Cip1)

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

Fluorescence and electron microscopy probes for cellular and tissue uptake of poly(D,L-lactide-co-glycolide) nanoparticles

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

Enhanced antiproliferative activity of transferrin-conjugated paclitaxel-loaded nanoparticles is mediated via sustained intracellular drug retention

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

Identifiers

DOI

10.1016/J.ACTBIO.2011.06.015

1 reference

12 September 2017

1 reference